Mackenzie Financial’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60,595
Closed -$418K 1758
2024
Q4
$418K Buy
60,595
+48,621
+406% +$334K ﹤0.01% 1248
2024
Q3
$88.2K Buy
+11,974
New +$112K ﹤0.01% 1497
2019
Q2
Sell
-50,039
Closed -$2.4M 1207
2019
Q1
$2.4M Buy
+50,039
New +$3.03M 0.01% 739
2018
Q4
Sell
-36,647
Closed -$3.02M 1206
2018
Q3
$3.02M Sell
36,647
-41,000
-53% -$3.26M 0.01% 584
2018
Q2
$6.07M Buy
+77,647
New +$6.01M 0.02% 408
2017
Q3
Sell
-24,850
Closed -$1.56M 661
2017
Q2
$1.56M Hold
24,850
0.01% 407
2017
Q1
$1.38M Sell
24,850
-59,382
-70% -$3.06M 0.01% 431
2016
Q4
$4.03M Buy
84,232
+24,650
+41% +$1.38M 0.02% 303
2016
Q3
$3.86M Buy
+59,582
New +$3.35M 0.02% 272

Other funds holding NUS

Mackenzie Financial's NUS Position: Q1 2025 in Review

Mackenzie Financial sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 60,595 shares — an estimated $418K sold.

Mackenzie Financial first reported a position in NUS in Q3 2016 and held it in 9 quarters. The position peaked at $6.07M in Q2 2018. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

  • Mackenzie Financial reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
  • Mackenzie Financial sold 60,595 Nu Skin shares in Q1 2025, an estimated $418K.
  • Mackenzie Financial first reported a position in Nu Skin in Q3 2016 and held it in 9 quarters.
  • Mackenzie Financial's Nu Skin position peaked at $6.07M in Q2 2018.
  • 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on Mackenzie Financial's 13F filing for Q1 2025, filed 7 May 2025.